Cargando…

Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder; it is the most common cause of dementia and has no treatment. It is characterized by two pathological hallmarks, the extracellular deposits of amyloid beta (Aβ) and the intraneuronal deposits of Neurofibrillary tangles (NFTs). Yet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Ghraiybah, Nour F., Wang, Junwei, Alkhalifa, Amer E., Roberts, Andrew B., Raj, Ruchika, Yang, Euitaek, Kaddoumi, Amal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502483/ https://www.ncbi.nlm.nih.gov/pubmed/36142483 http://dx.doi.org/10.3390/ijms231810572

Ejemplares similares

Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
por: Alkhalifa, Amer E., et al.
Publicado: (2023)

Comparison of Oleocanthal-Low EVOO and Oleocanthal against Amyloid-β and Related Pathology in a Mouse Model of Alzheimer’s Disease
por: Abdallah, Ihab M., et al.
Publicado: (2023)

Oleocanthal Ameliorates Metabolic and Behavioral Phenotypes in a Mouse Model of Alzheimer’s Disease
por: Yang, Euitaek, et al.
Publicado: (2023)

Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice
por: Abdallah, Ihab M., et al.
Publicado: (2021)

Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
por: Lee, Moonhee, et al.
Publicado: (2016)

Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease
por: Yang, Seung-Hoon
Publicado: (2019)

Calcineurin and glial signaling: neuroinflammation and beyond
por: Furman, Jennifer L, et al.
Publicado: (2014)

Neuroinflammation and glial cell activation in mental disorders
por: Almeida, Priscila G.C., et al.
Publicado: (2019)

Editorial: Linking Neuroinflammation and Glial Phenotypic Changes in Neurological Diseases
por: Tang, Yu, et al.
Publicado: (2019)

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
por: Refolo, Violetta, et al.
Publicado: (2019)

Neuroinflammation in Alzheimer’s disease
por: Zhang, Fengjin, et al.
Publicado: (2015)

Neuroinflammation in Alzheimer’s Disease
por: Onyango, Isaac G., et al.
Publicado: (2021)

Rodent models of neuroinflammation for Alzheimer’s disease
por: Nazem, Amir, et al.
Publicado: (2015)

Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
por: Barczuk, Julia, et al.
Publicado: (2022)

The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer’s Disease
por: Weng, Shiting, et al.
Publicado: (2022)

Neuroinflammation and Copper in Alzheimer's Disease
por: Choo, Xin Yi, et al.
Publicado: (2013)

Targeting neuroinflammation in Alzheimer’s disease
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2016)

The Blood–Brain Barrier in Health and Disease
por: Al Rihani, Sweilem B., et al.
Publicado: (2023)

Neuroinflammation induces glial aromatase expression in the uninjured songbird brain
por: Duncan, Kelli A, et al.
Publicado: (2011)

Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation
por: Gamage, Rashmi, et al.
Publicado: (2020)

Estimation of blood-based biomarkers of glial activation related to neuroinflammation
por: Yasuno, Fumihiko, et al.
Publicado: (2022)

Galectin-3: a key player in microglia-mediated neuroinflammation and Alzheimer's disease
por: Tan, Yinyin, et al.
Publicado: (2021)

Targeting Neuroinflammation to Treat Alzheimer’s Disease
por: Ardura-Fabregat, A., et al.
Publicado: (2017)

BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer's disease pathology
por: Zhang, Liansheng, et al.
Publicado: (2021)

TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus
por: Jayaraman, Anusha, et al.
Publicado: (2021)

AVE 0991 Suppresses Astrocyte-Mediated Neuroinflammation of Alzheimer’s Disease by Enhancing Autophagy
por: Deng, Yang, et al.
Publicado: (2023)

In vivo Imaging of Glial Activation in Alzheimer's Disease
por: Edison, Paul, et al.
Publicado: (2018)

Alzheimer’s disease is associated with disruption in thiamin transport physiology: A potential role for neuroinflammation
por: Ramamoorthy, Kalidas, et al.
Publicado: (2022)

Neuroinflammation in Alzheimer's disease wanes with age
por: Hoozemans, Jeroen JM, et al.
Publicado: (2011)

Brain injury, neuroinflammation and Alzheimer's disease
por: Breunig, Joshua J., et al.
Publicado: (2013)

Neuroinflammation in mouse models of Alzheimer's disease
por: Saito, Takashi, et al.
Publicado: (2018)

Neuroinflammation and fractalkine signaling in Alzheimer’s disease
por: Finneran, Dylan J., et al.
Publicado: (2019)

PET Imaging of Neuroinflammation in Alzheimer’s Disease
por: Zhou, Rong, et al.
Publicado: (2021)

Glial Response and Neuroinflammation in Cerebrocortical Atrophy in a Young Irish Wolfhound Dog
por: de Sant’Ana, Fabiano J. F., et al.
Publicado: (2021)

Viral CNS infections: role of glial pattern recognition receptors in neuroinflammation
por: Furr, Samantha R., et al.
Publicado: (2012)

Hypoxic Preconditioning Suppresses Glial Activation and Neuroinflammation in Neonatal Brain Insults
por: Chen, Chien-Yi, et al.
Publicado: (2015)

AST-120 Reduces Neuroinflammation Induced by Indoxyl Sulfate in Glial Cells
por: Adesso, Simona, et al.
Publicado: (2018)

Glial cell diversity and methamphetamine-induced neuroinflammation in human cerebral organoids
por: Dang, Jason, et al.
Publicado: (2020)

Neuroinflammation-Induced Upregulation of Glial Cathepsin X Expression and Activity in vivo
por: Pišlar, Anja, et al.
Publicado: (2020)

Neuroinflammation and glial activation in the central nervous system: a metabolic perspective
por: Virtuoso, Assunta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hogqp5ivhohn0heshu1hev16m7